Barclays and Truist have trimmed their price targets for Community Health Systems by about $0.50 each, signaling a more cautious stance on the hospital operator following the proposed Centers for Medicare and Medicaid Services rule. Barclays described the proposed rule as neutral to slightly negative for hospital stocks, while highlighting that an expansion of supplemental Medicaid payment cuts, including an 11% to 14% reduction in certain fee-for-service supplemental payments, could pressure margins and cash flow visibility. The fair value estimate remains unchanged at $3.31 per share, with forecast revenue contraction easing slightly from a decline of 1.76% to a decline of 1.74% and expected net profit margin effectively unchanged at about 1.18%. The future price-to-earnings multiple remains very high at about 480.21 times, and the discount rate is unchanged at 12.46%.
Barclays PLC
Truist Financial CorpCommunity Health Systems IncProposed CMS rule with supplemental payment cuts could pressure margins and cash flow.